DE3279435D1 - Base composition for preparing medicine for external application, medicinal composition for external application, and method for accelerating percutaneous absorption of medicinal agent - Google Patents

Base composition for preparing medicine for external application, medicinal composition for external application, and method for accelerating percutaneous absorption of medicinal agent

Info

Publication number
DE3279435D1
DE3279435D1 DE8282902831T DE3279435T DE3279435D1 DE 3279435 D1 DE3279435 D1 DE 3279435D1 DE 8282902831 T DE8282902831 T DE 8282902831T DE 3279435 T DE3279435 T DE 3279435T DE 3279435 D1 DE3279435 D1 DE 3279435D1
Authority
DE
Germany
Prior art keywords
external application
medicinal
composition
percutaneous absorption
preparing medicine
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
DE8282902831T
Other languages
English (en)
Inventor
Susumu Nitto Electric Ind Sato
Yumiko Nitto Electric I Nishiu
Mitsuru Nitto Electric Tamada
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Nitto Denko Corp
Original Assignee
Nitto Denko Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nitto Denko Corp filed Critical Nitto Denko Corp
Application granted granted Critical
Publication of DE3279435D1 publication Critical patent/DE3279435D1/de
Expired legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/14—Esters of carboxylic acids, e.g. fatty acid monoglycerides, medium-chain triglycerides, parabens or PEG fatty acid esters
DE8282902831T 1981-09-28 1982-09-24 Base composition for preparing medicine for external application, medicinal composition for external application, and method for accelerating percutaneous absorption of medicinal agent Expired DE3279435D1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP56154485A JPS5855411A (ja) 1981-09-28 1981-09-28 基剤組成物および外用医薬組成物
PCT/JP1982/000385 WO1983001000A1 (en) 1981-09-28 1982-09-24 Base composition for preparing medicine for external application, medicinal composition for external application, and method for accelerating percutaneous absorption of medicinal agent

Publications (1)

Publication Number Publication Date
DE3279435D1 true DE3279435D1 (en) 1989-03-16

Family

ID=15585268

Family Applications (1)

Application Number Title Priority Date Filing Date
DE8282902831T Expired DE3279435D1 (en) 1981-09-28 1982-09-24 Base composition for preparing medicine for external application, medicinal composition for external application, and method for accelerating percutaneous absorption of medicinal agent

Country Status (5)

Country Link
US (1) US4593048A (de)
EP (1) EP0091964B2 (de)
JP (1) JPS5855411A (de)
DE (1) DE3279435D1 (de)
WO (1) WO1983001000A1 (de)

Families Citing this family (39)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4537776A (en) * 1983-06-21 1985-08-27 The Procter & Gamble Company Penetrating topical pharmaceutical compositions containing N-(2-hydroxyethyl) pyrrolidone
CH643138A5 (de) * 1983-08-29 1984-05-30 Mepha Ag Indomethacin enthaltende, gelartige salbe.
US4605670A (en) * 1984-02-01 1986-08-12 Nitto Electric Industrial Co., Ltd. Method for percutaneously administering metoclopramide
IL75467A0 (en) * 1984-06-11 1985-10-31 Univ Bar Ilan Method and compositions for the therapeutic and prophylactic treatment of trauma to the skin
JPS6150913A (ja) * 1984-06-11 1986-03-13 バ−・イラン・ユニバ−シテイ− 外傷治療薬
DE3507175A1 (de) * 1985-03-01 1986-09-04 Basf Ag, 6700 Ludwigshafen Dicyclohexylalkane, ihre herstellung, diese enthaltende kosmetische und pharmazeutische zubereitungen und ihre verwendung als oelkomponente
DE3522550A1 (de) * 1985-06-24 1987-01-02 Klinge Co Chem Pharm Fab Aufspruehbare pharmazeutische zubereitung fuer die topische anwendung
JPH072628B2 (ja) * 1986-03-31 1995-01-18 日東電工株式会社 養毛組成物
US4863970A (en) * 1986-11-14 1989-09-05 Theratech, Inc. Penetration enhancement with binary system of oleic acid, oleins, and oleyl alcohol with lower alcohols
US5326790A (en) * 1986-11-19 1994-07-05 Dermatologic Research Corporation Administration of skin medications by use of dicarboxylic acids and derivatives
JP2764261B2 (ja) * 1987-03-17 1998-06-11 リ−ドケミカル株式会社 外用消炎鎮痛剤
US4849224A (en) * 1987-11-12 1989-07-18 Theratech Inc. Device for administering an active agent to the skin or mucosa
US4983395A (en) * 1987-11-12 1991-01-08 Theratech Inc. Device for administering an active agent to the skin or mucosa
US5013545A (en) * 1987-12-09 1991-05-07 Thames Pharmacal Co., Inc. Aqueous gels containing topical medicaments
US4942158A (en) * 1988-10-13 1990-07-17 Eastman Kodak Transdermal steroid penetrant compositions and methods utilizing isopropanol and isobutanol
US5026556A (en) * 1988-11-10 1991-06-25 Norwich Eaton Pharmaceuticals, Inc. Compositions for the transdermal delivery of pharmaceutical actives
US5164416A (en) * 1989-02-03 1992-11-17 Lintec Corporation Transdermal therapeutic formulation containing a limonene
JPH02293519A (ja) * 1989-05-09 1990-12-04 Daikin Ind Ltd 強制給排気方式温風暖房機の着火音低減装置
US4956171A (en) * 1989-07-21 1990-09-11 Paco Pharmaceutical Services, Inc. Transdermal drug delivery using a dual permeation enhancer and method of performing the same
JPH03232817A (ja) * 1990-02-07 1991-10-16 Showa Yakuhin Kako Kk 貼付剤
US5149719A (en) * 1990-04-27 1992-09-22 Minnesota Mining And Manufacturing Company Composition for transdermal penetration of medicaments
DE4210165A1 (de) * 1991-07-30 1993-02-04 Schering Ag Transdermale therapeutische systeme
IL108366A (en) * 1993-03-11 1999-11-30 Taro Vit Ind Ltd Semi-solid pharmaceutical compounds and a device for their use
EP0695179A1 (de) * 1993-04-22 1996-02-07 Minnesota Mining And Manufacturing Company Transdermale entzuendungshemmende zusammensetzung
DE69523745T2 (de) 1994-03-21 2002-08-08 Thomsen John Brown Gel zur behandlung von hauterkrankungen und zur desinfizierung von haut
DE4411557A1 (de) * 1994-04-02 1995-10-05 Henkel Kgaa Verfahren zur Herstellung von Mikroemulsionen
US5861439A (en) * 1994-11-14 1999-01-19 Alza Corporation Method for enhanced electrotransport agent delivery
US5702720A (en) * 1995-12-22 1997-12-30 Minnesota Mining And Manufacturing Company Transdermal device for the delivery of flurbiprofen
US6572880B2 (en) * 1996-10-24 2003-06-03 Pharmaceutical Applications Associates Llc Methods and transdermal compositions for pain relief
US6071523A (en) * 1998-06-03 2000-06-06 Taro Pharmaceuticals Industries, Ltd. Spill resistant pharmaceutical compositions in semi-solid form
DE60139134D1 (de) * 2000-09-21 2009-08-13 Henderson Morley Res & Dev Ltd Diuretikum oder sulfonylharnstoff zur benutzung in antiviraler behandlung
US20060189552A1 (en) * 2000-12-12 2006-08-24 Mohan Vishnupad Dispenser for dispensing three or more actives
US7060732B2 (en) * 2000-12-12 2006-06-13 Imaginative Research Associates, Inc. Antibiotic/benzoyl peroxide dispenser
WO2002096374A2 (en) * 2001-05-31 2002-12-05 Upsher-Smith Laboratories, Inc. Dermatological compositions and methods comprising alpha-hydroxy acids or derivatives
US20060122174A1 (en) * 2001-09-21 2006-06-08 Henderson Morley Research & Development Limited Antiviral treatment
WO2005072113A2 (en) * 2004-01-20 2005-08-11 Harty Richard F Compositions and methods of treatment for inflammatory diseases
US7662855B2 (en) * 2004-05-11 2010-02-16 Imaginative Research Associates, Inc. Retinoid solutions and formulations made therefrom
US20060014834A1 (en) * 2004-05-11 2006-01-19 Mohan Vishnupad Retinoid solutions and formulations made therefrom
DE102007034976A1 (de) 2007-07-26 2009-01-29 Bayer Healthcare Ag Arzneimittel zur transdermalen Anwendung bei Tieren

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL281225A (de) * 1961-07-20
JPS4950119A (de) * 1972-09-21 1974-05-15
JPS5532876B2 (de) * 1973-05-30 1980-08-27
GB1464553A (en) * 1974-02-08 1977-02-16 Fisons Ltd Anthelmintic treatment and composition
JPS51146408A (en) * 1975-06-09 1976-12-16 Nippon Saafuakutanto Kogyo Kk Process for preparation of glycerylethers
DE2748399C2 (de) * 1976-11-01 1983-09-15 The Procter & Gamble Co., 45202 Cincinnati, Ohio Antimikrobielles Mittel zur örtlichen Anwendung
GB2023000B (en) * 1978-06-17 1982-10-13 Kowa Co Antinflammatory analgesic gelled ointments

Also Published As

Publication number Publication date
JPH0317805B2 (de) 1991-03-11
EP0091964B1 (de) 1989-02-08
US4593048A (en) 1986-06-03
JPS5855411A (ja) 1983-04-01
EP0091964A4 (de) 1985-07-01
EP0091964A1 (de) 1983-10-26
WO1983001000A1 (en) 1983-03-31
EP0091964B2 (de) 1993-08-04

Similar Documents

Publication Publication Date Title
DE3279435D1 (en) Base composition for preparing medicine for external application, medicinal composition for external application, and method for accelerating percutaneous absorption of medicinal agent
DE3067536D1 (en) Powdery pharmaceutical composition and powdery preparation for application to the nasal mucosa, and method for administration thereof
EG17134A (en) Method and composition for the preparation of controlled long acting pharmaceuticals for oral administration
JPS57154122A (en) Administration vehicle for coadministration of drug and percutaneous absorption promoting agent
PH15719A (en) Aminoalkylbenzoic derivatives,pharmaceutical composition and method of use
PH24180A (en) Macrolide compounds,pharmaceutical composition containing said compound and method of use thereof
PH24093A (en) Macrolide compounds,pharmaceutical composition containing same and method of use thereof
DE3264523D1 (en) Derivatives of 4-aminoethoxy-5-isopropyl-2-methyl phenol, process for their preparation and their use as medicines
ZA848141B (en) New cyclic benzensulfonamides,process for their preparation and their use as active substance of pharmaceutical compositions
JPS57181060A (en) Imidazole derivatives, manufacture and medicinal composition containing them
DE3277838D1 (en) Thiazolylurea derivatives, process for their preparation, and medicinal composition containing same
DE3568985D1 (en) Retinoic-acid derivatives, process for their preparation and medicinal and cosmetic compositions containing them
DE3271383D1 (en) Ascochlorin derivatives; process for preparing the same and pharmaceutical composition containing the same
DE2966444D1 (en) Benzopyranotriazoles, preparation of these compounds and pharmaceutical composition containing them
PH19347A (en) Triazole derivatives,pharmaceutical composition containing same and method of use thereof
PT75265A (en) Process for the preparation of diazabicyclicononanes substituted and pharmaceutical composition containing them
DE3664635D1 (en) 7-hydroxyguanine compounds, process for preparing said compounds, pharmaceutical composition, and use thereof
EP0058079A3 (en) Imidazole derivative, method of preparation thereof, and pharmaceutical composition containing same
EP0084190A3 (en) Medicinal composition, package and method of making the composition
PT74400B (en) Process for the preparation of 17,18-dehydro-apovincaminol-3', 4',5'-trimethoxy-benzoate and of pharmaceutical compositions containing them
GB2109377B (en) Uracil derivatives, process for their preparation, and medicinal composition containing same
ZA824644B (en) Nitrosourea derivatives, process for preparing the same and pharmaceutical composition containing the same
PH13897A (en) 1-amino-3-aryloxy-2-propanols,pharmaceutical compositions containing same and method of preparing said compounds
GB2110674A (en) 2-thiazoleamine derivatives, process for their preparation, and medicinal composition containing same
JPS56142300A (en) Steroid-spiro-oxathiazolidine derivatives, manufacture and medicinal composition containing them

Legal Events

Date Code Title Description
8363 Opposition against the patent
8366 Restricted maintained after opposition proceedings
8339 Ceased/non-payment of the annual fee